Antiangiogenics in Malignant Pleural Mesothelioma: Recent Research Context
Malignant pleural mesothelioma (MPM) is a tough treatment course to navigate. If anyone knows that, it is Anne S. Tsao, MD. of MD Anderson Cancer Center in Houston. Tsao is no doubt one of the world's experts on MPM, having been "called" by the disease – one that is very rare and that generally occurs in older men (most often because of asbestos exposure) with comorbidities.
Tsao told the West Wind Podcast that she was intrigued by MPM early in her career because "it was so different than . I just started doing some!-->!-->!-->…